William Peter Castelli

William Peter Castelli's AcademicInfluence.com Rankings

Philosophy

#2835

World Rank

#4722

Historical Rank

Logic

#808

World Rank

#1351

Historical Rank

philosophy Degrees

Download Badge

Philosophy

William Peter Castelli's Degrees

Doctorate Medicine Harvard University

Why Is William Peter Castelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William Peter Castelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. (1977) (5082)
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. (1990) (3625)
The natural history of congestive heart failure: the Framingham study. (1971) (3183)
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. (1989) (3118)
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. (1983) (2551)
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. (1986) (2507)
Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study (1983) (2292)
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. (2020) (2112)
Role of diabetes in congestive heart failure: the Framingham study. (1974) (1921)
An investigation of coronary heart disease in families. The Framingham offspring study. (1979) (1654)
Fibrinogen and risk of cardiovascular disease. The Framingham Study. (1987) (1588)
HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study (1977) (1517)
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. (1979) (1312)
Cholesterol and mortality. 30 years of follow-up from the Framingham study. (1987) (1082)
Epidemiology of coronary heart disease: the Framingham study. (1984) (1075)
High-Density Lipoprotein Cholesterol and Cardiovascular Disease (2005) (946)
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. (1987) (868)
The Framingham Offspring Study. Design and preliminary data. (1975) (840)
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. (2020) (832)
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. (1987) (756)
Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. (1989) (701)
The triglyceride issue: a view from Framingham. (1986) (688)
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. (1970) (637)
Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. (1985) (620)
Role of blood pressure in the development of congestive heart failure. The Framingham study. (1972) (605)
ALCOHOL AND BLOOD LIPIDS The Cooperative Lipoprotein Phenotyping Study (1977) (599)
High density lipoprotein cholesterol and mortality. The Framingham Heart Study. (1988) (590)
Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. (1988) (585)
Lipoproteins, cardiovascular disease, and death. The Framingham study. (1981) (583)
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. (1990) (556)
Lipids and risk of coronary heart disease. The Framingham Study. (1992) (544)
Protective effect of fruits and vegetables on development of stroke in men. (1995) (544)
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. (1981) (543)
The aging thyroid. Thyroid deficiency in the Framingham Study. (1985) (457)
High Density Lipoprotein Cholesterol, Total Cholesterol Screening, and Myocardial Infarction: The Framingham Study (1988) (453)
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. (1996) (440)
Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. (1985) (412)
The prognostic significance of proteinuria: the Framingham study. (1984) (410)
The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. (1987) (407)
Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. (1987) (403)
Summary Estimates of Cholesterol Used to Predict Coronary Heart Disease (1983) (399)
Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. (1977) (396)
Coronary risk prediction in adults (the Framingham Heart Study) (1987) (382)
Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study. (1992) (379)
Epidemiology of triglycerides: a view from Framingham. (1992) (360)
Lipids, risk factors and ischaemic heart disease. (1996) (359)
A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. (1986) (359)
Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. (1983) (339)
Triglyceride, high density lipoprotein, and coronary heart disease. (1993) (335)
Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. (1980) (334)
Gout and coronary heart disease: the Framingham Study. (1988) (327)
Effects of Age, Sex, and Menopausal Status on Plasma Lipoprotein(a) Levels The Framingham Offspring Study (1993) (324)
Cigarette smoking and HDL cholesterol: the Framingham offspring study. (1978) (315)
Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. (1994) (299)
Plasma lipids and lipoproteins in vegetarians and controls. (1975) (289)
A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. (1994) (278)
Risk factors for pulmonary embolism. The Framingham Study. (1983) (250)
LDL particle size distribution. Results from the Framingham Offspring Study. (1992) (246)
Blood pressure aggregation in families. (1979) (243)
Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. (1994) (237)
Predicting coronary heart disease in middle-aged and older persons. The Framington study. (1977) (235)
Weight and thirty-year mortality of men in the Framingham Study. (1985) (232)
Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. (1994) (213)
Obesity, lipids, and glucose intolerance. The Framingham Study. (1979) (211)
Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). (1990) (207)
Cardiovascular risk factors in the elderly. (1989) (204)
Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. (1994) (204)
Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates. (1989) (200)
Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. (1994) (198)
Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham Study). (1983) (187)
Cigarette smoking as a confounder of the relationship between relative weight and long-term mortality. The Framingham Heart Study. (1983) (180)
Cardiovascular disease in women. (1988) (168)
Obesity and lipoprotein cholesterol in the Framingham offspring study. (1980) (166)
Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. (1990) (162)
Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study. (1983) (160)
Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring. (1987) (159)
Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. (1977) (154)
Mitral valve prolapse in the general population. 3. Dysrhythmias: the Framingham Study. (1983) (147)
Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. (1999) (145)
Relation of alcohol intake to left ventricular mass: The Framingham Study. (1991) (142)
Latest Perspectives on Cigarette Smoking and Cardiovascular Disease: The Framingham Study (1984) (136)
Cardiovascular disease and multifactorial risk: challenge of the 1980s. (1983) (130)
The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). (1991) (120)
The coronary profile: 12-year follow-up in the Framingham study. (1967) (116)
The association of total cholesterol, triglycerides and plasma lipoprotein cholesterol levels in first degree relatives and spouse pairs. (1979) (116)
Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. (1987) (115)
The aging thyroid. The use of thyroid hormone in older persons. (1989) (106)
Blood pressure and survival after myocardial infarction: the Framingham study. (1980) (106)
Factors Associated with Lipoprotein Cholesterol Levels: The Framingham Study (1983) (104)
Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. (1984) (98)
Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. (1991) (98)
Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. (1983) (97)
Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. (1983) (92)
Effect of ingestion of meat on plasma cholesterol of vegetarians. (1981) (90)
Elevated high-density lipoprotein levels in marathon runners. (1980) (90)
Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma. (1981) (86)
THE FILTER CIGARETTE AND CORONARY HEART DISEASE: THE FRAMINGHAM STUDY (1981) (85)
The Framingham Heart Study--the future. (1987) (78)
The new pathophysiology of coronary artery disease. (1998) (76)
The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. (1985) (70)
Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. (1985) (67)
Role of lipids and lipoprotein fractions in atherogenesis: the Framingham study. (1981) (64)
Vital Capacity and Congestive Heart Failure: The Framingham Study (1974) (63)
Role of blood pressure in the development of congestive heart failure: The framingham study☆ (1972) (62)
Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study. (1989) (59)
Postmenopausal estrogen use and heart disease. (1986) (57)
Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke. (1999) (55)
Margarine Intake and Subsequent Coronary Heart Disease in Men (1997) (55)
Effect of vitamin E on lipids. (1983) (55)
Evidence for Additional Blood Pressure Correlates in Adults 20‐56 Years Old (1980) (50)
Systemic side effects of topical beta‐adrenergic blockers (1996) (49)
Alcohol consumption and high-density lipoprotein cholesterol in marathon runners. (1980) (46)
Plasma lipoproteins in healthy octogenarians: lack of reduced high density lipoprotein cholesterol levels: results from the Framingham Heart Study. (1989) (46)
Heparin and human lipid metabolism. (1969) (45)
Electrocardiographic changes with advancing age. A cross-sectional study of the association of age with QRS axis, duration and voltage. (1987) (45)
Genetics of plasma cholesterol and triglycerides: a study of adult male twins. (1974) (43)
Cigarette smoking and risk of coronary heart disease. Epidemiologic clues to pathogensis. The Framingham Study. (1968) (41)
Some Factors Affecting Morbidity and Mortality in Hypertension: The Framingham Study (1969) (41)
Prevalence and correlates of posterior extra echocardiographic spaces in a free-living population based sample (the Framingham study). (1983) (41)
Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoring. (1987) (40)
Cholesterol content of red blood cells and low-density lipoproteins in hypertriglyceridemia. (1983) (32)
Plasma cholesterol variation in the national heart, lung and blood institute twin study (1987) (32)
Sudden unexpected death during ambulatory electrocardiographic monitoring. The Framingham Study. (1983) (31)
Echocardiographic left ventricular hypertrophy: clinical characteristics. The Framingham Heart Study. (1992) (30)
Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. The Framingham Heart Study. (1989) (29)
IS THE SERUM TOTAL CHOLESTEROL AN ANACHRONISM? (1979) (29)
The value of measuring vital capacity for prognostic purposes. (1980) (29)
A comparison of blood pressure, total cholesterol and cigarette smoking in parents in 1950 and their children in 1970. (1979) (28)
EFFECTS OF FAT AND CARBOHYDRATE INGESTION IN HUMAN BEINGS ON SERUM LIPIDS AND INTRACELLULAR LIPID DEPOSITION IN TISSUE CULTURE. (1964) (28)
Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study. (1977) (25)
Identification and Assessment of Cardiac Risk—An Overview (1985) (25)
The Framingham study of coronary disease in women. (1972) (24)
Concerning the possibility of a nut... (1992) (24)
High Density Lipoproteins: An Overview (1980) (23)
High density lipoprotein cholesterol. A 16-year longitudinal study in aging male twins. (1990) (22)
Lipoproteins and cardiovascular disease: biological basis and epidemiological studies. (1998) (22)
Cardiovascular risk factors and graded treadmill exercise endurance in healthy adults: The Framingham Offspring Study. (1989) (22)
Serum prolactin and aging: basal values and changes with estrogen use and hypothyroidism. (1989) (21)
HDL-cholesterol in a sample of black adults: the Framingham Minority Study. (1983) (20)
Diet, smoking, and alcohol: influence on coronary heart disease risk. (1990) (20)
Mitral Valve Prolapse in Blacks (1982) (19)
Serum nefa following fat, carbohydrate and protein ingestion, and during fasting as related to intracellular lipid deposition (1966) (18)
Serum lipid fractions and risk of coronary heart disease. The Framingham study. (1969) (17)
CHD risk factors in the elderly. (1976) (17)
Epidemiology of Coronary Atherosclerosis: Postmortem vs Clinical Risk Factor Correlations. The Framingham Study (1980) (16)
Quantitation of beta lipoprotein (LDL) cholesterol by densitometric evaluation of disc electropherograms. (1972) (16)
Epidemiologic assessment of angina before and after myocardial infarction: The Framingham study. (1996) (16)
How many drinks a day? (1979) (14)
Fat macroglobulinemia and fat embolism. (1968) (14)
Electrocardiographic Left Ventricular Hypertrophy and Risk of Coronary Heart Disease. The Framingham Study (1971) (13)
Celebrating 40 years of the Framingham Heart Study. (1987) (13)
Type A behavior and mortality from coronary disease in the Framingham study. (1988) (13)
Coronary heart disease risk: the importance of joint relationships among cholesterol levels in individual lipoprotein classes. (1982) (13)
The fact and fiction of lowering cholesterol concentrations in the primary prevention of coronary heart disease. (1993) (11)
Effect of carbohydrate ingestion in humans on intracellular lipid deposition in tissue culture. (1967) (10)
Lipid studies for assessing the risk of cardiovascular disease and hyperlipidemia. (1971) (10)
Effect of Growth Hormone on Plasma Triglycerides in Man 1 (1973) (9)
Fibrinogen and Cardiovascular Disease (1985) (9)
Insights From the Framingham Study (2016) (9)
Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort (2020) (8)
Evaluation and management of eating disorders : anorexia, bulimia, and obesity (1988) (8)
Lipemia retinalis: microcirculatory changes and lipid studies in a family. (1969) (8)
Profile of the coronary-prone individual. Assessment of risk of developing coronary heart disease. The Framingham study. (1967) (8)
Cholesterol in the Prediction of Atherosclerotic Disease (2020) (7)
Fat particles in plasma. The macroglobule: its relevance to the concept of fat embolism. (1971) (7)
Mitral valve prolapse in the general population: Epidemiologic features — The Framingham and Framingham minority studies (1982) (7)
Mitral valve prolapse and risk of stroke. (1983) (7)
Heart failure and hypertension. (1972) (7)
Making practical sense of clinical trial data in decreasing cardiovascular risk. (2001) (6)
The omnicardiogram Study of a proposed method for detecting coronary heart disease in an asymptomatic population. (1975) (6)
Silent myocardial ischemia in asymptomatic survivors of unrecognized myocardial infarction and matched controls. (1988) (6)
The folly of questioning the benefits of cholesterol reduction. (1994) (5)
Cholesterol reduction and life expectancy. (1988) (5)
The role of plasma lipids as predictors of risk of coronary heart disease. Discussion (1990) (4)
How to help patients cut down on saturated fat. A simple strategy. (1988) (4)
Semi-Automatic Remote Gas-Liquid Chromatographic Analysis (1967) (4)
Coronary heart disease in women (2005) (4)
The Framingham Heart Study--thirty years. (1987) (3)
The Role of Plasma Lipids as Predictors of Risk for Coronary Heart Disease (2012) (3)
Nutrition, Lipids, and Coronary Heart Disease: A Global View; Nutrition in Health and Disease (1979) (3)
Thyroid Deficiency in the Framingham Study (2017) (3)
Echocardiographic Left Ventricular Hypertrophy: C1 inical Characteristics. (1992) (3)
Risk Factors in the Elderly: A View From Framingham. (1993) (3)
Section V—Determinants of CHD Mortality: Genetic, Socioeconomic, Lifestyle and Risk Factor Influences—An Overview (1989) (3)
Natural disease investigation: Atherosclerosis, blood cholesterol, and the environment (1982) (3)
Cardiovascular disease and lipoproteins: available evidence and remaining questions. Reactor panel and open forum. (1998) (3)
[Framingham 36 years later]. (1987) (2)
Fruits, Vegetables, and Stroke Risk-Reply (1995) (2)
From phenotype to genotype. (2001) (2)
Exercise and high-density lipoproteins. (1979) (2)
Does epidemiology define the individual at risk (1994) (2)
Triglycerides and serum cholesterol. (1991) (2)
Mortality significance of hypercholesterolemia and hypertriglyceridemia. (1975) (1)
Type of hypercholesterolemia and risk of coronary heart disease. The framingham study (1969) (1)
Noninvasive cardiology tools and endpoints in genetic epidemiology: the Framingham Study. (1984) (1)
FILTER CIGARETTES AND HEART DISEASE (1981) (1)
The Lipid Hypothesis: Is it the Only Cause of Atherosclerosis? (1992) (1)
Report of the National Heart and Lung Institute Panel on Hyperlipidemia and Premature Atherosclerosis (1970) (1)
Round table discussion: practical issues in the management of dyslipidaemic patients. (1996) (0)
Ultrasound as Used in the Framingham Hearl Study (1990) (0)
Whither Triglycerides in the Cholesterol Campaign (1992) (0)
[Clinical risk factors in coronary disease. The Framingham study]. (1982) (0)
Increased relative weight — A risk factor for major pulmonary embolism: The Framingham study (1982) (0)
Blood Pressure and Lipids: Dangerous Companions (1994) (0)
Epidemiology of Triglycerides (1993) (0)
A Prospective Investigation ofElevated Lipoprotein (a)Detected byElectrophoresis and Cardiovascular Disease inWomen TheFramingham HeartStudy (1994) (0)
[Cholesterol. The complex relation of an indispensable enemy. Interview by Robert Henry]. (1990) (0)
Alcohol consumption and high density lipoprotein cholesterol in marathon runners. (1980) (0)
Blood pressure and survival following myocardial infarction: The Framingham study (1978) (0)
If we ever quizzed our patients. (1997) (0)
Role of Lipid Profiles in Assessing Atherogenesis (1983) (0)
Quantitationof BetaLipoprotein ( LDL ) Cholesterolby DensitometricEvaluationof DiscElectropherograms (2004) (0)
Estimationof Very-Low-DensityLipoproteinCholesterolfrom Data on TriglycerideConcentrationin Plasma (2004) (0)
[With hypertension under control, Dr. William Castelli now can attack coronary disease. Interview by Robert Henry]. (1987) (0)
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice? (1998) (0)
William Peter Castelli, MD: a conversation with the editor [interview by William Clifford Roberts]. (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William Peter Castelli?

William Peter Castelli is affiliated with the following schools: